drugset / Trial / NCT02999022
Lithium for Fracture Treatment: a Double Blind Randomized Controlled Trial (LiFT)
Phase 2
Unknown
160 enrolled
Sunnybrook Health Sciences Centre
Canadian Institutes of Health Research (CIHR) · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a study designed to see if a low dose of Lithium treatment, taken for 2 weeks, can improve fracture healing and improve patients' function and productivity.
Timeline
- Start
- 2017-07-21
- Primary completion
- 2024-12
- Completion
- 2025-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lithium Carbonate | Unknown | 300 mg | — |
Indications
No indication recorded.